BIOMAT Database Logo BIOMAT Database Logo

[Comparison of labetalol as a single treatment and labetalol combined with chlorthalidone in the treatment of severe arterial hypertension]. 1988

F Franco, and G Colombo, and G Salvioli, and E Planca

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002752 Chlorthalidone A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic. Chlorphthalidolone,Phthalamudine,Chlortalidone,Hygroton,Oxodoline,Thalitone
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Franco, and G Colombo, and G Salvioli, and E Planca
[Spironolactone combined with chlorthalidone in the treatment of essential arterial hypertension].
April 1975, Minerva medica,
F Franco, and G Colombo, and G Salvioli, and E Planca
Combined labetalol plus flunarizine treatment for arterial hypertension.
January 1984, International journal of clinical pharmacology research,
F Franco, and G Colombo, and G Salvioli, and E Planca
[Treatment of arterial hypertension with chlorthalidone].
July 1962, Revista espanola de cardiologia,
F Franco, and G Colombo, and G Salvioli, and E Planca
Use of the the combination labetalol plus chlorthalidone in essential arterial hypertension therapy.
January 1981, Clinical therapeutics,
F Franco, and G Colombo, and G Salvioli, and E Planca
[Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
April 1981, La Nouvelle presse medicale,
F Franco, and G Colombo, and G Salvioli, and E Planca
[Labetalol treatment of patients with arterial hypertension].
September 1988, Vrachebnoe delo,
F Franco, and G Colombo, and G Salvioli, and E Planca
Treatment of severe hypertension with intravenous labetalol.
October 1982, Clinical pharmacology and therapeutics,
F Franco, and G Colombo, and G Salvioli, and E Planca
Treatment of severe hypertension with peroral labetalol.
January 1987, Upsala journal of medical sciences,
F Franco, and G Colombo, and G Salvioli, and E Planca
[Treatment of arterial hypertension with labetalol. A polycentric study].
January 1982, Giornale italiano di cardiologia,
F Franco, and G Colombo, and G Salvioli, and E Planca
Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study.
January 1982, European journal of clinical pharmacology,
Copied contents to your clipboard!